TheJobsMapAravax jobs and careers
Melbourne, Australia
About Aravax
Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.
Founded in 2015 by Robyn O'Hehir and Sara Prickett.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $42.2M
- Headquarters
- Melbourne
Leadership
The top of Aravax's org chart, with how many people report into each leader.
Pascal Hickey
Chief Executive Officer
5 reports
Paul Laidler
Vice President, Pharmaceutical Development
Aled Williams
Chief Business Officer (CBO)
Adrian Parry
Director Of CMC
Rohina Batra
CFO
Annette Leahy
Director Clinical Operations
Jobs at Aravax
No open positions right now. Explore more companies on TheJobsMap.